These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 30590261)
1. Identification and characterization of a novel nanobody against duck hepatitis A virus type 1. Xue W; Zhao Q; Li P; Zhang R; Lan J; Wang J; Yang X; Xie Z; Jiang S Virology; 2019 Feb; 528():101-109. PubMed ID: 30590261 [TBL] [Abstract][Full Text] [Related]
2. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3. Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545 [TBL] [Abstract][Full Text] [Related]
3. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein. Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372 [TBL] [Abstract][Full Text] [Related]
4. Mapping a Type-specific Epitope by Monoclonal Antibody against VP3 Protein of Duck Hepatitis A Type 1 Virus. Wu X; Zhang T; Meng F; Guo D; Yin X; Wulin S; Li C; Zhang Q; Liu M; Zhang Y Sci Rep; 2017 Sep; 7(1):10820. PubMed ID: 28883462 [TBL] [Abstract][Full Text] [Related]
5. Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity. Li X; Zhao R; Lin W; Li C; Zhang T; Meng F; Liu M; Zhang Y Virus Res; 2017 Jan; 227():240-244. PubMed ID: 27816429 [TBL] [Abstract][Full Text] [Related]
6. Preparation of single-chain antibody against VP3 protein of duck hepatitis virus type 1 by phage display technology. Wang Y; Cui P; Zhu S; Meng T; Hao F; Zhu G; Zuo W J Virol Methods; 2018 Jul; 257():73-78. PubMed ID: 29727718 [TBL] [Abstract][Full Text] [Related]
7. Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability. Ma X; Sheng Z; Huang B; Qi L; Li Y; Yu K; Liu C; Qin Z; Wang D; Song M; Li F PLoS One; 2015; 10(7):e0132982. PubMed ID: 26173145 [TBL] [Abstract][Full Text] [Related]
8. [Indirect ELISA for simultaneous detection of antibodies against duck hepatitis A type 1 and 3 viruses]. Zhang Y; Ma X; Huang B; Li Y; Yu K; Li J; Liu C; Han H; Cui Y Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):501-9. PubMed ID: 26211325 [TBL] [Abstract][Full Text] [Related]
9. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355 [TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies against duck hepatitis type 1 virus VP1 protein. Zhang T; Li X; Wu X; Shaozhou W; Bai X; Liu S; Liu M; Zhang Y J Virol Methods; 2014 Nov; 208():166-70. PubMed ID: 25110119 [TBL] [Abstract][Full Text] [Related]
11. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks. Zhang R; Yang Y; Lan J; Xie Z; Zhang X; Jiang S Transbound Emerg Dis; 2021 Mar; 68(2):267-275. PubMed ID: 32598568 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of an indirect ELISA based on recombinant nonstructural protein 3A to detect antibodies to duck hepatitis A virus type 1. Zhou S; Zhang S; Wang M; Cheng A; Zhu D; Chen S; Liu M; Zhao X; Jia R; Yang Q; Wu Y; Zhang S; Liu Y; Yu Y; Zhang L; Chen X J Virol Methods; 2019 Jun; 268():56-61. PubMed ID: 30905595 [TBL] [Abstract][Full Text] [Related]
13. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt. Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161 [TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3. Zhang X; Cao C; Qu Z; Zhang W; Liu Y; Qi H; Hao C; Zhang W; Gao M; Wang J; Ma B Mol Immunol; 2018 Mar; 95():30-38. PubMed ID: 29407574 [TBL] [Abstract][Full Text] [Related]
15. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies. Roh JH; Kang M Vet Microbiol; 2018 Jun; 219():107-112. PubMed ID: 29778181 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015. Wen X; Zhu D; Cheng A; Wang M; Chen S; Jia R; Liu M; Sun K; Zhao X; Yang Q; Wu Y; Chen X Transbound Emerg Dis; 2018 Feb; 65(1):10-15. PubMed ID: 29076646 [TBL] [Abstract][Full Text] [Related]
17. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Liu R; Shi S; Huang Y; Chen Z; Chen C; Cheng L; Fu G; Chen H; Wan C; Fu Q Vet Microbiol; 2019 Jan; 228():181-187. PubMed ID: 30593365 [TBL] [Abstract][Full Text] [Related]
18. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay. Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848 [TBL] [Abstract][Full Text] [Related]
19. A Novel Peptide Isolated from a Phage Display Peptide Library Modeling Antigenic Epitope of DHAV-1 and DHAV-3. Zhang R; Yang Y; Lan J; Lin S; Xie Z; Zhang X; Jiang S Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32150877 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings. Kang M; Roh JH; Jang HK Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]